# clm_F20B9ABE4C44

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 2,695,000,000 United States dollar  
valid_from: 2024-03-31  
valid_to: 2024-06-30  
published: 2024-04-25  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_505BDAA1FD80  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 2,695,000,000 United States dollar", as of 2024-03-31 (until 2024-06-30). Claim clm_F20B9ABE4C44, https://asof.is/claim/clm_F20B9ABE4C44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2024, filed 2024-04-25  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/0000014272-24-000096-index.htm (primary, SEC EDGAR 10-Q Q1 FY2024, published 2024-04-25)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,242,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_F20B9ABE4C44](/claim/clm_F20B9ABE4C44.md) | [clm_3B07EC588400](/claim/clm_3B07EC588400.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.